LAVIPHARM S.A. NA EO 1 (BXA0) — Capital Reinvestment Ratio
LAVIPHARM S.A. NA EO 1 (BXA0) has a Capital Reinvestment Ratio of 2.08x as of December 2024, meaning it reinvests 2% of its operating cash flow (€4.64 Million) in capital expenditures (€9.64 Million). See BXA0 net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
LAVIPHARM S.A. NA EO 1 Capital Reinvestment Ratio (2021–2024)
This chart tracks LAVIPHARM S.A. NA EO 1's Capital Reinvestment Ratio across 4 annual periods. Check LAVIPHARM S.A. NA EO 1 (BXA0) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for LAVIPHARM S.A. NA EO 1 (2021–2024)
Year-by-year Capital Reinvestment Ratio for LAVIPHARM S.A. NA EO 1 from 2021 to 2024. For live market cap and broader valuation context, see how much is LAVIPHARM S.A. NA EO 1 worth.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 2.08x | €4.64 Million | €9.64 Million | ▼ -85.4% |
| 2023 | 14.26x | €284.00K | €4.05 Million | ▲ +33.9% |
| 2022 | 10.64x | €3.35 Million | €35.62 Million | ▲ +2181.6% |
| 2021 | 0.47x | €4.11 Million | €1.92 Million | — |